Cancer treatment works best when it is guided by a clear understanding of a patient’s unique tumor biology. OncoIndx® is a comprehensive genomic profiling test by 1Cell.Ai that analyzes over 1,000 genes using next-generation sequencing and AI-powered reporting. For oncologists, it means sharper visibility into targetable mutations, therapy resistance, and clinical trial eligibility, all from a single test using either a tissue sample or a simple blood draw.
For patients, especially those with advanced or treatment-resistant cancers, OncoIndx® takes the guesswork out of treatment decisions. Instead of a one-size-fits-all approach, your oncologist can use your tumor’s genetic profile to find therapies most likely to work for you. The test covers a wide range of cancers including lung, breast, colorectal, ovarian, and more, with results delivered in 10 to 14 days through the AI-driven iCare™ platform.
Our whitepaper dives deeper into the clinical evidence, technical validation, and real-world applications of OncoIndx®. Whether you are a clinician looking to integrate precision oncology into your practice or a patient wanting to understand your options, this resource is built for you. Download the whitepaper below to learn more.